Cargando…

Animal models demonstrating respiratory responses to inhalant antigens.

Detalles Bibliográficos
Autor principal:	Patterson, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Yale Journal of Biology and Medicine 1968
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2591627/ https://www.ncbi.nlm.nih.gov/pubmed/4970616

Ejemplares similares

A novel large animal model of smoke inhalation-induced acute respiratory distress syndrome
por: Leiphrakpam, Premila D., et al.
Publicado: (2021)

Inhalation exposure of animals.
por: Phalen, R F
Publicado: (1976)

Hypersensitivity to Inhaled Organic Antigens
por: Pepys, J.
Publicado: (1967)

Inhaled particles in human disease and animal models: use of electron beam instrumentation.
por: Brody, A R
Publicado: (1984)

Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19
por: Sonti, Rajiv, et al.
Publicado: (2020)

Respiratory Immune Responses during Infection and Pollution Inhalation
por: McCarthy, Cormac, et al.
Publicado: (2023)

PBTK Modeling Demonstrates Contribution of Dermal and Inhalation Exposure Components to End-Exhaled Breath Concentrations of Naphthalene
por: Kim, David, et al.
Publicado: (2007)

Folk medical inhalants in respiratory disorders.
por: Hand, W D
Publicado: (1968)

Fluticasone Furoate, a Novel Inhaled Corticosteroid, Demonstrates Prolonged Lung Absorption Kinetics in Man Compared with Inhaled Fluticasone Propionate
por: Allen, Ann, et al.
Publicado: (2012)

Inhalation toxicity of mycotoxins in farm animals
por: Prathap-Kumar, K., et al.
Publicado: (2023)

Effects of inhaled acids on respiratory tract defense mechanisms.
por: Schlesinger, R B
Publicado: (1985)

A Pre-clinical Animal Model of Trypanosoma brucei Infection Demonstrating Cardiac Dysfunction
por: McCarroll, Charlotte S., et al.
Publicado: (2015)

Inhalable hybrid nanocarriers for respiratory disorders
por: Maurya, Priyanka, et al.
Publicado: (2020)

Decreased Hippocampal Neuroplasticity and Behavioral Impairment in an Animal Model of Inhalant Abuse
por: Malloul, Hanaa, et al.
Publicado: (2018)

Comparative pathology of the nasal mucosa in laboratory animals exposed to inhaled irritants.
por: Harkema, J R
Publicado: (1990)

ABO Blood Group Is Associated with Response to Inhaled Nitric Oxide in Neonates with Respiratory Failure
por: El-Ferzli, George T., et al.
Publicado: (2012)

Immunoassay for Capsular Antigen of Bacillus anthracis Enables Rapid Diagnosis in a Rabbit Model of Inhalational Anthrax
por: Gates-Hollingsworth, Marcellene A., et al.
Publicado: (2015)

Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen
por: Doss-Gollin, Simon, et al.
Publicado: (2023)

Chronic toxicity of inhaled thymol in lungs and respiratory tracts in mouse model
por: Xie, Kevin, et al.
Publicado: (2019)

Critical errors found during metered dose inhaler technique demonstration by Pharmacists
por: Adnan, Muhammad, et al.
Publicado: (2016)

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
por: Barnes, Kay B., et al.
Publicado: (2017)

Preliminary observations of the effect of inhalation of PVC in man and experimental animals.
por: Wagner, J C, et al.
Publicado: (1981)

Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule
por: Nagy, CF, et al.
Publicado: (2016)

Rapid Capsular Antigen Immunoassay for Diagnosis of Inhalational Anthrax: Preclinical Studies and Evaluation in a Nonhuman Primate Model
por: Gates-Hollingsworth, Marcellene A., et al.
Publicado: (2022)

Comparing Inhaler Use Technique Based on Inhaler Type in Elderly Patients with Respiratory Disease
por: Lee, Ha Youn, et al.
Publicado: (2021)

In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
por: Movia, Dania, et al.
Publicado: (2020)

A phenylthiazole derivative demonstrates efficacy on treatment of the cryptococcosis & candidiasis in animal models
por: Sá, Nívea P, et al.
Publicado: (2018)

Animal model of Mycoplasma fermentans respiratory infection
por: Yáñez, Antonio, et al.
Publicado: (2013)

Experimental Evaluation of Dry Powder Inhalers during Inhalation and Exhalation Using a Model of the Human Respiratory System (xPULM™)
por: Pasteka, Richard, et al.
Publicado: (2022)

On the Inhalation of Carbolic Acid in Diseases of the Respiratory Organs
por: Munro, Robert
Publicado: (1880)

Practical Guide to the Demonstration of Bacteria in Animal Tissues
Publicado: (1890)

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes
por: Bosnic-Anticevich, Sinthia, et al.
Publicado: (2016)

Pulmonary response to inhaled carbon: a model of lung injury.
por: Boren, H. G.
Publicado: (1968)

Acute Respiratory Distress Due to Methane Inhalation
por: Jo, Jun Yeon, et al.
Publicado: (2013)

Inhaled Antibiotic Therapy in Chronic Respiratory Diseases
por: Maselli, Diego J., et al.
Publicado: (2017)

Inhalation of Medicated Vapors in Diseases of the Respiratory Organs
Publicado: (1882)

Comparative study of individual and traditional bedside metered-dose inhaler use and group teaching with video demonstration
por: Tafti, Saeid Fallah, et al.
Publicado: (2011)

Inhalation of Ortho-Phthalaldehyde Vapor Causes Respiratory Sensitization in Mice
por: Johnson, Victor J., et al.
Publicado: (2011)

The effects of respiratory inhaled drugs on the prevention of acute mountain sickness
por: Wang, Xiaomei, et al.
Publicado: (2018)

Cichoric acid aerosol for inhalation therapy in respiratory syncytial virus
por: Feng, Anjie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_05vd05gaoatvmbqh8f1m2su6b0